TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.40$ +3.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Codexis Inc (CDXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 148 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CDXS
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
47 114 71 99 141 136 100 59 48 45 36 54 78 149 222 246 250 137 149 148
37 93 48 67 92 79 60 36 33 33 27 45 67 114 184 162 163 93 99 97
32 55 22 32 72 26 32 22 26 23 19 31 53 90 149 117 114 65 19 51
32 84 37 56 72 53 46 25 26 23 19 31 53 90 150 117 114 65 73 78
2.8 6.4 6.2 7.2 15 19 7.5 5.4 3.9 7.3 5.9 12 13 20 29 38 41 20 19 11
1.0 1.6 3.0 2.9 2.8 4.5 1.3 1.5 1.4 1.0 0.8 1.0 0.6 0.4 1.0 1.2 2.0 2.7 1.8 1.8
16 22 21 24 17 8.4 4.0 3.1 2.2 2.8 4.8 6.3 9.7 65 62
1.9 3.1 3.1 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 2.5 2.5 2.5
2.3 2.8 1.8 0.9 20 16 13 9.6 6.2 2.8 3.2 3.2
99 201 200 62 34 33 22 17 22 22 17 29 22 44 52 82 106 50 82 97
14 34 42 49 27 28 16 11 14 15 12 25 17 15 25 33 49 36 24 25
1.6 4.5 5.2 5.4 0.0 0.4 0.4 0.4 0.4 1.2 2.6 4.1 5.4 3.8 2.8 2.9
2.5 4.2 9.2 10.0 9.2 10 3.7 4.0 4.7 3.4 4.2 3.5 3.1 2.6 3.0 3.0 3.2 5.9 2.8 1.6
8.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 29 40
-53 -87 -129 105 107 103 78 41 26 23 19 25 56 106 170 164 145 87 67 51
-55 -94 -139 -160 -168 -185 -216 -257 -276 -284 -292 -315 -330 -342 -366 -388 -421 -498 -563 -607
2.7 2.7 2.7 2.6 25 36 37 38 38 39 41 46 52 57 59 65 65 68 73 87

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?